While Alzheimer's drug developers have spent US$50 billion on suboptimal treatments, Actinogen strives for a breakthrough ...

A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...

The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...

HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy, HKEY-AIRxTM1.0  designed to address one of the most persis ...

Thermo Fisher Scientific’s Accelerator Drug Development is a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from early-stage research to ...

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...